Amneal Pharmaceuticals, Inc. AMRX Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s inventories?
- Amneal Pharmaceuticals, Inc. (AMRX) reported inventories of $641.62M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s inventories changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s inventories increased by 6.7% year-over-year, from $601.43M to $641.62M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s inventories?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s inventories has grown at a 4.3% compound annual growth rate (CAGR), from $490.65M to $606.3M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.